Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.59 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.59 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.59 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.59 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.59 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29709386 | 1.00 | ESR1 (0.59) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1042192 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1041379 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1040975 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1042359 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1041460 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1038973 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1040814 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL22497786 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 | |
| SCHEMBL1038902 | 0.98 | ESR1 (0.61) | ESR1LMNATSHRMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3946240-B1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO KGAA (DE) | 2025-10-15 | — | — | EP | claimed |
| CN-113677319-A | Increasing the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2021-11-19 | — | — | CN | claimed |
| WO-2024204339-A1 | POSITIVE PHOTOSENSITIVE PIGMENT COMPOSITION, CURED PRODUCT, AND ORGANIC EL DISPLAY DEVICE | 東レ株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-114308121-B | Phosphine oxide catalyst and preparation method and application thereof | 浙江工业大学 | 2024-02-23 | — | — | CN | disclosed |
| CN-114308121-A | Phosphine oxide catalyst and preparation method and application thereof | 浙江工业大学 | 2022-04-12 | — | — | CN | disclosed |
| EP-3946240-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-02-09 | — | — | EP | disclosed |
| CN-113677319-A | Increasing the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2021-11-19 | — | — | CN | disclosed |
| WO-2020200545-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020200545-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2020-10-08 | — | — | WO | disclosed |
| US-8871861-B2 | Silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | RICOH COMPANY, LTD. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20120283378-A1 | A SILICONE COMPOUND, PHOTOCURABLE LIQUID INK USING THE SILICONE COMPOUND, AND METHOD OF MANUFACTURING THE INK | RICOH COMPANY, LTD., (JP) | 2012-11-08 | — | — | US | disclosed |
| US-20040077018-A1 | Chemiluminescent 1,2-dioxetanes | GIRI BRIJ P (US) | 2004-04-22 | — | — | US | disclosed |
| US-20030213940-A1 | Chemiluminescent 1,2-dioxetanes | GIRI BRIJ P (US) | 2003-11-20 | — | — | US | disclosed |
| WO-2003054506-A2 | DEUTERIUM-BASED CHEMILUMINESCENT 1,2-DIOXETANES | GIRI BRIJ PAL (US) | 2003-07-03 | — | — | WO | disclosed |
| US-6461876-B1 | STABLE SPIROFUSED RINGS; DECOMPOSING TO GENERATE LIGHT AND CARBONYL GROUP; HIGH ENERGY; MEDICINE | TOBEN, HOWARD R. | 2002-10-08 | — | — | US | disclosed |
| EP-1112274-A4 | CHEMILUMINESCENT 1,2-DIOXETANES | GIRI BRIJ P (US) | 2002-06-12 | — | — | EP | disclosed |
| US-20020013250-A1 | Single molecule detection of alkaline phosphatase enzyme using enhanced chemiluminescence from 1,2-dioxetanes and water-soluble, water-insoluble or partially-water soluble polymers | GIRI BRIJ P (US) | 2002-01-31 | — | — | US | disclosed |
| EP-1112274-A1 | CHEMILUMINESCENT 1,2-DIOXETANES | Giri, Brij P. (US) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000014092-A1 | CHEMILUMINESCENT 1,2-DIOXETANES | GIRI BRIJ P (US) | 2000-03-16 | — | — | WO | disclosed |
| US-4689171-A | LIQUID CRYSTALS | BAYER AKTIENGESELLSCHAFT (DE) | 1987-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077018-A1 | Chemiluminescent 1,2-dioxetanes | CYP19A1, CYP1A1, CYP2F1 | ESR1 548/4885LMNA 2716/4885TSHR 1049/4885 |
| US-20120283378-A1 | A SILICONE COMPOUND, PHOTOCURABLE LIQUID INK USING THE SILICONE COMPOUND, AND METHOD OF MANUFACTURING THE INK | DOT1L, L3MBTL3, KDM7A | ESR1 215/4885LMNA 179/4885TSHR 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.